BEVERLY MAUGER: Open Payments
NPI 1548529084 · FT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$92,852 in 123 payments from 6 companies in 2025. Trend: 2023 $201 · 2024 $0 · 2025 $92,852
Speaker / faculty: $75,944Travel & lodging: $7,391Consulting: $6,750Food & beverage: $2,688Education: $80
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 100 | $92,123 |
| Teva Pharmaceuticals USA, Inc. | 3 | $207 |
| E.R. Squibb & Sons, L.L.C. | 10 | $200 |
| Otsuka America Pharmaceutical, Inc. | 7 | $158 |
| ACADIA Pharmaceuticals Inc | 2 | $147 |
| Alkermes, Inc. | 1 | $17 |
Products named: INGREZZA, REXULTI, COBENFY, NUPLAZID, AUSTEDO XR, ARISTADA.
Industry payments across IN — which companies pay providers there.
